Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0107 | 0.6315 | 0.8342 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.1116 | 0.4071 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0164 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.2503 | 1 |
Brugia malayi | hypothetical protein | 0.0036 | 0.0164 | 0.0655 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.1116 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0164 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.2503 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2503 | 0.2503 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0119 | 0.7348 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2503 | 0.2503 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0119 | 0.7348 | 1 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.2503 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.1362 | 0.5442 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.1116 | 0.5 |
Leishmania major | trypanothione reductase | 0.0047 | 0.1116 | 0.5 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0107 | 0.6315 | 0.8342 |
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.1116 | 0.5 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0107 | 0.6315 | 0.8342 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.1116 | 0.4459 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.1362 | 0.5442 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0119 | 0.7348 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.2503 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.1116 | 0.4459 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2503 | 0.2503 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.1362 | 0.5442 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0164 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.2503 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.1116 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0164 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.2503 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.2503 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2503 | 0.2503 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0107 | 0.6315 | 0.8342 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.1116 | 0.4071 |
Mycobacterium tuberculosis | Probable reductase | 0.0107 | 0.6315 | 0.8342 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0119 | 0.7348 | 1 |
Brugia malayi | RNA binding protein | 0.0063 | 0.2503 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.1116 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.1116 | 0.5 |
Brugia malayi | glutathione reductase | 0.0047 | 0.1116 | 0.4459 |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.1116 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0164 | 0.0164 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.1116 | 0.4459 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2503 | 0.2503 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0107 | 0.6315 | 0.8342 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1362 | 0.5442 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.0164 | 0.0164 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.289 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.251 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.094 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.034 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.971 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.783 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.709 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.491 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.